Docs Who Lift cover image

From Injections to Pills: Breaking Down the New Oral GLP-1 Data

Docs Who Lift

00:00

Orforglipron (ATTain-1) results and clinical significance

Dr. Wharton presents orforglipron outcomes: 11.2% and 12.4% weight loss over 72 weeks and highlights categorical responder rates.

Play episode from 16:54
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app